Delivery Order SPE2DB25D3110-SPE2DB26FTCFG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Januvia 50 mg tablets (90-count packages) with a contract value of $1,056.72. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 50 mg tablets (90-count) valued at $1,316.00. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was awarded on a competitive, non-set-aside basis. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Januvia 50 mg tablets (90-count units) at a ceiling value of $3,252.65. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count) valued at $1,122.26 under a firm fixed price contract. This delivery order, issued on August 27, 2025, with completion scheduled for August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,637.19. The delivery order, which represents a child contract under a larger vehicle, carries an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Januvia 50 mg tablets (90-count) with a ceiling value of $1,091.46. This is a firm fixed price contract with an ultimate completion date of September 29, 2025. The award was made through competitive procurement with no set-aside designation, leveraging AmerisourceBergen's established position as a critical pharmaceutical distributor for federal medical procurement. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,413.42 for Januvia 50 mg tablets (90-count units) on October 15, 2025, with completion expected by October 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB26FTCFGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Januvia 50 mg tablets (90-count units) with a ceiling value of $1,075.19. This contract represents a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and is not designated as a set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare procurement needs. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, medical supplies, vaccines, and related healthcare commodities to support military healthcare programs worldwide. Through this competitive contract arrangement, the company supplies critical pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating its significant role in the federal medical supply chain.